(Q34802516)

4 August 2017

1 reference

title

Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry (English)

1 reference

4 August 2017

liver transplantation

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

2

Goran B Klintmalm

1 reference

4 August 2017

Ernesto P Molmenti

1

1 reference

4 August 2017

1 September 2002

1 reference

4 August 2017

Liver Transplantation

1 reference

4 August 2017

8

1 reference

4 August 2017

9

1 reference

4 August 2017

736-748

1 reference

Hepatobiliary malignancies. Primary hepatic malignant neoplasms

4 August 2017

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

The Hepatitis-B Virus and Hepatocellular Carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Percutaneous fine-needle aspiration of portal vein thrombi as a staging technique for hepatocellular carcinoma. Cytologic findings of 46 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Needle tract recurrence of hepatocellular carcinoma after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Hepatocellular cancer in liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Clinical trials in primary hepatocellular carcinoma: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Hepatic resection in 120 patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Risk factors for tumor recurrence and prognosis after curative resection of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Hepatoma in the noncirrhotic liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

An analysis of 412 cases of hepatocellular carcinoma at a Western center

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

21 January 2018

Fibrolamellar hepatoma

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Is liver transplantation justified for the treatment of hepatic malignancies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Role of liver transplantation in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Liver transplantation for malignant disease. Results in 93 consecutive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

The role of liver transplantation in hepatobiliary malignancy. A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Experience with transplantation in the treatment of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Current treatment modalities for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Liver transplantation for hepatocellular carcinoma: clinical results and future aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Hepatic resection versus transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Surgical treatment of hepatocellular carcinoma: Experience with liver resection and transplantation in 198 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

The prediction of risk of recurrence and time to recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

The current status of liver transplantation for primary hepatic malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Prognosis of hepatocellular carcinoma: the BCLC staging classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Liver transplantation for primary hepatocellular carcinoma: tumor size and number determine outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Is the pathologic TNM staging system for patients with hepatoma predictive of outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Recurrent hepatocellular carcinoma after liver transplantation: spectrum of CT findings and recurrence patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Treatment of fibrolamellar hepatoma with subtotal hepatectomy or transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Appraisal of transplantation for malignant tumours of the liver with special reference to early stage hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation: biologic and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Nonresectional therapies for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

Increased hepatic oxidative DNA damage in patients with hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJLTS.2002.34879

21 January 2018

Identifiers

DOI

10.1053/JLTS.2002.34879

1 reference

4 August 2017

1 reference

PubMed ID

12200772